bismuth subsalicylate 262 MG Oral Tablet [Pepto-bismol]
RxNorm concept 702384, branded drug (sbd). Prescribable name: Pepto-Bismol 262 MG Oral Tablet.
- RxCUI
- 702384
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/702384 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- bismuth subsalicylate 262 MG (SCDC, consists of)
- bismuth subsalicylate 262 MG [Pepto-bismol] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Pepto-bismol (BN, has ingredient)
- bismuth subsalicylate 262 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00149003990
- 00149003991
- 37000047602
- 37000047603
- 58933047601
- 58933047602
- 58933047603
- 58933047612
- 76420049024
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 702384 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/702384 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 702384. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.